PubMed

A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease.

Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, Tjora S, Domanski MJ, Gersh BJ, Rouleau JL, Pfeffer MA, Braunwald E; the Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators.

N Engl J Med. 2009 Nov 25. [Epub ahead of print]PMID: 19940289 [PubMed - as supplied by publisher]

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R; TREAT Investigators.

N Engl J Med. 2009 Nov 19;361(21):2019-32. Epub 2009 Oct 30.PMID: 19880844 [PubMed - in process]Related articles

Adherence to medication according to sex and age in the CHARM programme.

Granger BB, Ekman I, Granger CB, Ostergren J, Olofsson B, Michelson E, McMurray JJ, Yusuf S, Pfeffer MA, Swedberg K.

Eur J Heart Fail. 2009 Nov;11(11):1092-8.PMID: 19875409 [PubMed - in process]Related articles

Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial.

Piccini JP, Zhang M, Pieper K, Solomon SD, Al-Khatib SM, Van de Werf F, Pfeffer MA, McMurray JJ, Califf RM, Velazquez EJ.

Eur Heart J. 2009 Oct 23. [Epub ahead of print]PMID: 19854729 [PubMed - as supplied by publisher]Related articles

Acute Decline in Renal Function, Inflammation, and Cardiovascular Risk after an Acute Coronary Syndrome.

Mielniczuk LM, Pfeffer MA, Lewis EF, Blazing MA, Lemos JA, Mohanavelu S, Rouleau J, Fox K, Pedersen TR, Califf RM.

Clin J Am Soc Nephrol. 2009 Oct 9. [Epub ahead of print]PMID: 19820133 [PubMed - as supplied by publisher]Related articles

Predictors of heart failure in patients with stable coronary artery disease: a PEACE study.

Lewis EF, Solomon SD, Jablonski KA, Rice MM, Clemenza F, Hsia J, Maggioni AP, Zabalgoitia M, Huynh T, Cuddy TE, Gersh BJ, Rouleau J, Braunwald E, Pfeffer MA; PEACE Investigators.

Circ Heart Fail. 2009 May;2(3):209-16. Epub 2009 Apr 14.PMID: 19808342 [PubMed - indexed for MEDLINE]Related articles

Cardiac-resynchronization therapy for the prevention of heart-failure events.

Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W; MADIT-CRT Trial Investigators.

N Engl J Med. 2009 Oct 1;361(14):1329-38. Epub 2009 Sep 1.PMID: 19723701 [PubMed - indexed for MEDLINE]Related articles

Albuminuria in chronic heart failure: prevalence and prognostic importance.

Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, Granger CB, Swedberg K, Pfeffer MA, Yusuf S, McMurray JJ; CHARM Investigators and Committees.

Lancet. 2009 Aug 15;374(9689):543-50.PMID: 19683640 [PubMed - indexed for MEDLINE]Related articles

Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial.

McMurray JJ, Anand IS, Diaz R, Maggioni AP, O'Connor C, Pfeffer MA, Polu KR, Solomon SD, Sun Y, Swedberg K, Tendera M, van Veldhuisen DJ, Wasserman SM, Young JB; RED-HF Committees and Investigators.

Eur J Heart Fail. 2009 Aug;11(8):795-801.PMID: 19633103 [PubMed - in process]Related articles

Dual renin-angiotensin system blockade and kidney disease.

Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Pfeffer MA.

J Am Coll Cardiol. 2009 Jul 14;54(3):278-9; author reply 279-80. No abstract available. PMID: 19589445 [PubMed - indexed for MEDLINE]Related articles

Dual renin-angiotensin system blockade in heart failure.

McMurray JJ, Granger CB, Ostergren J, Yusuf S, Pfeffer MA, Swedberg K.

J Am Coll Cardiol. 2009 Jul 14;54(3):278; author reply 279-80. No abstract available. PMID: 19589444 [PubMed - indexed for MEDLINE]Related articles

Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).

Califf RM, Lokhnygina Y, Velazquez EJ, McMurray JJ, Leimberger JD, Lewis EF, Diaz R, Murin J, Pfeffer MA.

Am J Cardiol. 2009 Jul 15;104(2):151-7. Epub 2009 Jun 3.PMID: 19576338 [PubMed - indexed for MEDLINE]Related articles

Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial.

Moukarbel GV, Signorovitch JE, Pfeffer MA, McMurray JJ, White HD, Maggioni AP, Velazquez EJ, Califf RM, Scheiman JM, Solomon SD.

Eur Heart J. 2009 Sep;30(18):2226-32. Epub 2009 Jun 25.PMID: 19556260 [PubMed - in process]Related articles

Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill J, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R, Uno H; TREAT Investigators.

Am J Kidney Dis. 2009 Jul;54(1):59-69. Epub 2009 Jun 5.PMID: 19501439 [PubMed - indexed for MEDLINE]Related articles

Infarct haemorrhage detected by cardiac magnetic resonance imaging: are we seeing the latest culprit in adverse left ventricular remodelling?

Kwong RY, Pfeffer MA.

Eur Heart J. 2009 Jun;30(12):1431-3. Epub 2009 May 21. No abstract available. PMID: 19460842 [PubMed - indexed for MEDLINE]Related articles

Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.

Verma A, Meris A, Skali H, Ghali JK, Arnold JM, Bourgoun M, Velazquez EJ, McMurray JJ, Kober L, Pfeffer MA, Califf RM, Solomon SD.

JACC Cardiovasc Imaging. 2008 Sep;1(5):582-91.PMID: 19356485 [PubMed - indexed for MEDLINE]Related articles

Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT).

Berry C, Pieper KS, White HD, Solomon SD, Van de Werf F, Velazquez EJ, Maggioni AP, Califf RM, Pfeffer MA, McMurray JJ.

Eur Heart J. 2009 Jun;30(12):1450-6. Epub 2009 Apr 3.PMID: 19346225 [PubMed - indexed for MEDLINE]Related articles

Red blood cell distribution width and mortality risk in a community-based prospective cohort.

Perlstein TS, Weuve J, Pfeffer MA, Beckman JA.

Arch Intern Med. 2009 Mar 23;169(6):588-94.PMID: 19307522 [PubMed - indexed for MEDLINE]Related articles

Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program.

Preiss D, Zetterstrand S, McMurray JJ, Ostergren J, Michelson EL, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, Gerstein HC, Sattar N; Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity Investigators.

Diabetes Care. 2009 May;32(5):915-20. Epub 2009 Feb 5.PMID: 19196892 [PubMed - indexed for MEDLINE]Related articlesFree article

Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

Hawkins NM, Huang Z, Pieper KS, Solomon SD, Kober L, Velazquez EJ, Swedberg K, Pfeffer MA, McMurray JJ, Maggioni AP; Valsartan in Acute Myocardial Infarction Trial Investigators.

Eur J Heart Fail. 2009 Mar;11(3):292-8. Epub 2009 Jan 27.PMID: 19176539 [PubMed - indexed for MEDLINE]Related articles

Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program.

Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB; CHARM Investigators.

Eur J Heart Fail. 2009 Feb;11(2):170-7.PMID: 19168515 [PubMed - indexed for MEDLINE]Related articles

Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.

Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Ghadanfar M, Weissbach N, Xiang Z, Armbrecht J, Pfeffer MA.

Nephrol Dial Transplant. 2009 May;24(5):1663-71. Epub 2009 Jan 14.PMID: 19145003 [PubMed - indexed for MEDLINE]Related articles

Leapfrogging data: no shortcuts for safety or efficacy information.

Pfeffer MA, Sacks FM.

Circulation. 2008 Dec 9;118(24):2491-4. Review. No abstract available. PMID: 19064690 [PubMed - indexed for MEDLINE]Related articles

Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program.

Meredith PA, Ostergren J, Anand I, Puu M, Solomon SD, Michelson EL, Olofsson B, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, McMurray JJ.

J Am Coll Cardiol. 2008 Dec 9;52(24):2000-7.PMID: 19055992 [PubMed - indexed for MEDLINE]Related articles

Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.

Bostom AG, Carpenter MA, Hunsicker L, Jacques PF, Kusek JW, Levey AS, McKenney JL, Mercier RY, Pfeffer MA, Selhub J; FAVORIT Study Investigators.

Am J Kidney Dis. 2009 Jan;53(1):121-8. Epub 2008 Nov 20.PMID: 19022547 [PubMed - indexed for MEDLINE]Related articles

Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study.

Meris A, Amigoni M, Uno H, Thune JJ, Verma A, Køber L, Bourgoun M, McMurray JJ, Velazquez EJ, Maggioni AP, Ghali J, Arnold JM, Zelenkofske S, Pfeffer MA, Solomon SD.

Eur Heart J. 2009 Jan;30(1):56-65. Epub 2008 Nov 11.PMID: 19001474 [PubMed - indexed for MEDLINE]Related articles

Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programme.

Cohen-Solal A, McMurray JJ, Swedberg K, Pfeffer MA, Puu M, Solomon SD, Michelson EL, Yusuf S, Granger CB; CHARM Investigators.

Eur Heart J. 2008 Dec;29(24):3022-8. Epub 2008 Nov 5.PMID: 18987098 [PubMed - indexed for MEDLINE]Related articles

Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction.

Tian L, Cai T, Pfeffer MA, Piankov N, Cremieux PY, Wei LJ.

Biostatistics. 2009 Apr;10(2):275-81. Epub 2008 Oct 14.PMID: 18922759 [PubMed - indexed for MEDLINE]Related articles

Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme.

Pocock SJ, McMurray JJ, Dobson J, Yusuf S, Granger CB, Michelson EL, Ostergren J, Pfeffer MA, Solomon SD, Anker SD, Swedberg KB.

Eur Heart J. 2008 Nov;29(21):2641-50. Epub 2008 Sep 26.PMID: 18819960 [PubMed - indexed for MEDLINE]Related articlesFree article

The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program.

Gerstein HC, Swedberg K, Carlsson J, McMurray JJ, Michelson EL, Olofsson B, Pfeffer MA, Yusuf S; CHARM Program Investigators.

Arch Intern Med. 2008 Aug 11;168(15):1699-704.PMID: 18695086 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial.

Tardif JC, McMurray JJ, Klug E, Small R, Schumi J, Choi J, Cooper J, Scott R, Lewis EF, L'Allier PL, Pfeffer MA; Aggressive Reduction of Inflammation Stops Events (ARISE) Trial Investigators.

Lancet. 2008 May 24;371(9626):1761-8.PMID: 18502300 [PubMed - indexed for MEDLINE]Related articles

Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both.

Prisant LM, Thomas KL, Lewis EF, Huang Z, Francis GS, Weaver WD, Pfeffer MA, McMurray JJ, Califf RM, Velazquez EJ.

J Am Coll Cardiol. 2008 May 13;51(19):1865-71.PMID: 18466801 [PubMed - indexed for MEDLINE]Related articles

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.

MacDonald MR, Petrie MC, Varyani F, Ostergren J, Michelson EL, Young JB, Solomon SD, Granger CB, Swedberg K, Yusuf S, Pfeffer MA, McMurray JJ; CHARM Investigators.

Eur Heart J. 2008 Jun;29(11):1377-85. Epub 2008 Apr 14.PMID: 18413309 [PubMed - indexed for MEDLINE]Related articlesFree article

Anemia treatment in chronic kidney disease: shifting uncertainty.

Pfeffer MA.

Heart Fail Rev. 2008 Dec;13(4):425-30. Epub 2008 Apr 10. Review.PMID: 18401704 [PubMed - indexed for MEDLINE]Related articles

Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome.

Mielniczuk LM, Pfeffer MA, Lewis EF, Blazing MA, de Lemos JA, Shui A, Mohanavelu S, Califf RM, Braunwald E.

Am Heart J. 2008 Apr;155(4):725-31. Epub 2008 Feb 21.PMID: 18371483 [PubMed - indexed for MEDLINE]Related articles

High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.

Anderson RE, Pfeffer MA, Thune JJ, McMurray JJ, Califf RM, Velazquez E, White HD, Rouleau JL, Skali H, Maggioni A, Solomon SD.

Am Heart J. 2008 Apr;155(4):706-11. Epub 2008 Jan 31.PMID: 18371480 [PubMed - indexed for MEDLINE]Related articles

Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus.

Anavekar NS, Solomon SD, McMurray JJ, Maggioni A, Rouleau JL, Califf R, White H, Kober L, Velazquez E, Pfeffer MA.

Am J Cardiol. 2008 Apr 1;101(7):925-9.PMID: 18359309 [PubMed - indexed for MEDLINE]Related articles

Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W).

Healey JS, Hart RG, Pogue J, Pfeffer MA, Hohnloser SH, De Caterina R, Flaker G, Yusuf S, Connolly SJ.

Stroke. 2008 May;39(5):1482-6. Epub 2008 Mar 6.PMID: 18323500 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.

Lewis EF, Velazquez EJ, Solomon SD, Hellkamp AS, McMurray JJ, Mathias J, Rouleau JL, Maggioni AP, Swedberg K, Kober L, White H, Dalby AJ, Francis GS, Zannad F, Califf RM, Pfeffer MA.

Eur Heart J. 2008 Mar;29(6):748-56. Epub 2008 Feb 28.PMID: 18308687 [PubMed - indexed for MEDLINE]Related articlesFree article

Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study).

Anavekar NS, Skali H, Bourgoun M, Ghali JK, Kober L, Maggioni AP, McMurray JJ, Velazquez E, Califf R, Pfeffer MA, Solomon SD.

Am J Cardiol. 2008 Mar 1;101(5):607-12.PMID: 18308007 [PubMed - indexed for MEDLINE]Related articles

Critical missing data on erythropoiesis-stimulating agents in CKD: first beat placebo.

Pfeffer MA.

Am J Kidney Dis. 2008 Mar;51(3):366-9. No abstract available. PMID: 18295051 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.

Weir RA, McMurray JJ, Puu M, Solomon SD, Olofsson B, Granger CB, Yusuf S, Michelson EL, Swedberg K, Pfeffer MA; CHARM Investigators.

Eur J Heart Fail. 2008 Feb;10(2):157-63. Epub 2008 Jan 31.PMID: 18242128 [PubMed - indexed for MEDLINE]Related articles

Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials.

Iakoubova OA, Tong CH, Rowland CM, Kirchgessner TG, Young BA, Arellano AR, Shiffman D, Sabatine MS, Campos H, Packard CJ, Pfeffer MA, White TJ, Braunwald E, Shepherd J, Devlin JJ, Sacks FM.

J Am Coll Cardiol. 2008 Jan 29;51(4):435-43.PMID: 18222353 [PubMed - indexed for MEDLINE]Related articles

Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy.

Sabatine MS, Ploughman L, Simonsen KL, Iakoubova OA, Kirchgessner TG, Ranade K, Tsuchihashi Z, Zerba KE, Long DU, Tong CH, Packard CJ, Pfeffer MA, Devlin JJ, Shepherd J, Campos H, Sacks FM, Braunwald E.

Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):562-7. Epub 2008 Jan 3.PMID: 18174457 [PubMed - indexed for MEDLINE]Related articlesFree article

Aortic diameter, wall stiffness, and wave reflection in systolic hypertension.

Mitchell GF, Conlin PR, Dunlap ME, Lacourcière Y, Arnold JM, Ogilvie RI, Neutel J, Izzo JL Jr, Pfeffer MA.

Hypertension. 2008 Jan;51(1):105-11. Epub 2007 Dec 10.PMID: 18071054 [PubMed - indexed for MEDLINE]Related articlesFree article

Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.

Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ; ACTIVE W Investigators.

J Am Coll Cardiol. 2007 Nov 27;50(22):2156-61. Epub 2007 Nov 13.PMID: 18036454 [PubMed - indexed for MEDLINE]Related articles

Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease.

Solomon SD, Lin J, Solomon CG, Jablonski KA, Rice MM, Steffes M, Domanski M, Hsia J, Gersh BJ, Arnold JM, Rouleau J, Braunwald E, Pfeffer MA; Prevention of Events With ACE Inhibition (PEACE) Investigators.

Circulation. 2007 Dec 4;116(23):2687-93. Epub 2007 Nov 19.PMID: 18025537 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction.

Thune JJ, Signorovitch J, Kober L, Velazquez EJ, McMurray JJ, Califf RM, Maggioni AP, Rouleau JL, Howlett J, Zelenkofske S, Pfeffer MA, Solomon SD.

Hypertension. 2008 Jan;51(1):48-54. Epub 2007 Nov 19.PMID: 18025296 [PubMed - indexed for MEDLINE]Related articlesFree article

Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program.

Desai AS, Swedberg K, McMurray JJ, Granger CB, Yusuf S, Young JB, Dunlap ME, Solomon SD, Hainer JW, Olofsson B, Michelson EL, Pfeffer MA; CHARM Program Investigators.

J Am Coll Cardiol. 2007 Nov 13;50(20):1959-66. Epub 2007 Oct 29.PMID: 17996561 [PubMed - indexed for MEDLINE]Related articles

The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study.

Verma A, Anavekar NS, Meris A, Thune JJ, Arnold JM, Ghali JK, Velazquez EJ, McMurray JJ, Pfeffer MA, Solomon SD.

J Am Coll Cardiol. 2007 Sep 25;50(13):1238-45. Epub 2007 Sep 10.PMID: 17888840 [PubMed - indexed for MEDLINE]Related articles